15th Jun 2020 13:05
Faron Pharmaceuticals Oy - Turku-based biopharmaceutical firm - Receives EUR2.1 million low interest rate loan from government innovation financing agency Business Finland. Funds to go towards developing and selecting new cell line that can be used for future commercial scale production of Faron's human interferon beta-1a. Loan is for seven-year period with repayment commencing after three years.
Current stock price: 335.00 pence
Year-to-date change: up 21%
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Faron Pharmaceuticals